DiaSorin S.p.A. (BIT: DIA)
Italy
· Delayed Price · Currency is EUR
100.25
+0.81 (0.81%)
Dec 20, 2024, 5:35 PM CET
DiaSorin Company Description
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally.
It provides various immunodiagnostic LIAISON chemiluminescence analyzers under LIAISON XL and LIAISON XS name; and Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens.
The company was founded in 1968 and is headquartered in Saluggia, Italy.
DiaSorin S.p.A.
Country | Italy |
Founded | 1968 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 3,233 |
CEO | Carlo Rosa |
Contact Details
Address: Via Crescentino snc Saluggia, Vercelli 13040 Italy | |
Phone | 39 016 1487526 |
Website | int.diasorin.com |
Stock Details
Ticker Symbol | DIA |
Exchange | Borsa Italiana |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | IT0003492391 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Carlo Rosa | Chief Executive Officer, GM and Executive Director |
Dr. Chen Menachem Even | Chief Commercial Officer, Senior Corporate Vice President of Commercial Operations and Executive Director |
Piergiorgio Pedron | Senior Corporate Vice President, Chief Financial Officer and Corporate Accounting Documents Officer |
Fabrizio Piercarlo Bonelli | Corporate Vice President and Chief Technology Officer |
Dr. Riccardo Fava | Corporate Vice President of Communication, ESG and Investor Relations |
Ulisse Spada | Corporate Vice President, Head of the Legal Department, Secretary and General Counsel |
Amelia Parente | Senior Corporate Vice President of Human Resources |
Angelo Rago | President of Luminex Corporation |